Invoke Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4

- Investments
-
14
- Portfolio
-
3
- Exits
-
3

Invoke Capital General Information
Description
Founded in 2012, Invoke Capital is a venture capital firm based in London, United Kingdom. The firm seeks to invest in early-stage companies focused on the genomics, security, big data, science, and technology sectors.
Contact Information
Website
www.invokecapital.com
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 6 Duke Street
- Saint James
- London SW1Y 6BN
- England, United Kingdom
+44 020 0000 0000
Invoke Capital Investments (14)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Featurespace | 13-May-2020 | Later Stage VC | 000.00 | Network Management Software | Generating Revenue | 000000 0000000 |
000000000 | 07-Feb-2019 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | 0000000 0000000 |
000000000000 | 25-Jan-2019 | 00000 00000 | 000.00 | Network Management Software | Generating Revenue | 000000 0000000 |
000000000 | 29-Nov-2017 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | 0000000 00000 00.0 |
000000000000 | 04-Oct-2017 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | 0000000 00000 00.0 |
000000 00000000 | 01-Jun-2017 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue/Not Profitable | 0000000 00000 00.0 |
000000000 | 15-Dec-2016 | 00000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 0000000 00000 00.0 |
000000000 | 06-Jul-2016 | 00000 00000 | 000.00 | Network Management Software | Profitable | 0000000 00000 00.0 |
Darktrace | 18-Mar-2015 | Early Stage VC | 000.00 | Network Management Software | Profitable | 0000000 00000 00.0 |
Neurence | 18-Dec-2014 | Buyout/LBO | 000 | Business/Productivity Software | Generating Revenue | 0000000 00000 00.0 |
Invoke Capital Exits (3)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
SOPHiA GENETICS | 23-Jul-2021 | IPO | 00000 |
000000000 | 30-Apr-2021 | 000 | 00000 |
000000 | 01-Nov-2019 | 000 00 00000000 |
Invoke Capital Investments by Industry, Year, and Region
Invoke Capital Team (10)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Vanessa Colomar | Co-Founder, Partner & Executive Investor Relations | 0 | 0 | 0 | London, United Kingdom |
Charlotte Golunski | Partner | 0 | London, United Kingdom | ||
Mike Lynch Ph.D | Co-Founder | London, United Kingdom | |||
Ella Mamelok | Senior Associate | London, United Kingdom |
Invoke Capital Co-Investors (10)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Gray Ventures | 1 | 0 |
![]() |
![]() |
|
IP Group | 0 | 0 |
![]() |
![]() |
|
Insight Partners | 0 | 0 |
![]() |
![]() |
|
Slaughter and May | 0 | 0 |
![]() |
![]() |
|
TTV Capital | 0 | 0 |
![]() |
![]() |